Authentidate's Telehealth Solution Featured in Nephrology News Issues(R ... - MarketWatch |
BERKELEY HEIGHTS, N.J., Jul 23, 2015 (GLOBE NEWSWIRE via COMTEX) --
Authentidate Holding Corp.
ADAT, +7.06%
a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations was featured this month in an article in Nephrology News & Issues®, a publication that integrates the business and practice of quality kidney care.
The article, Renal Ventures Program to Start Remotely Monitoring Incident Dialysis Patients, written by Rebecca Zumoff, covered the recent announcement that Renal Ventures Management (RVM) would begin remotely monitoring a selection of their dialysis patients using Telehealth Solutions from Authentidate in an effort to decrease hospitalizations and mortality. Each dialysis patient in the program will be enrolled in a specific disease management protocol that will allow case managers to remotely manage and direct patient care.
Authentidate's Telehealth Solution is designed to help patients achieve their goals to get healthy and stay healthy with an easy to use mobile device that captures vital signs, symptoms, and treatment plan compliance in the home and shares the associated data in real time with the patient's care givers via the internet.
George R. Aronoff, MD, Chief Medical Officer of RVM told the publication, "Depending on their co-morbidities, patients may also be supplied with a glucometer, weight scale, BP cuff and oximeter that will record results back to the tablet via Bluetooth and then to a secure clinical portal website hosted by Authentidate. Our case managers and physicians then will access patient information from their PCs by logging on to the clinical portal. The case managers will also be able to interact with patients utilizing a camera on the tablets, if needed. Using remote patient management, we will be able to interact with these patients daily."
Commenting on how patients were being selected he said, "We chose incident patients because, according to USRDS data, they have very high hospitalization and mortality rates."
Aronoff also said they are also considering using the data that they collect to feed advanced decision support tools using predictive analytics to determine who among incident patients are the most at risk for hospitalizations and other adverse events.
The article can be read in its entirety at the following link: http://www.nephrologynews.com/renal-ventures-program-to-start-remote-monitoring-incident-dialysis-patients/
About Authentidate Holding Corp.
Authentidate Holding Corp. is a provider of web-based revenue cycle management applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Authentidate's products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate's telehealth solutions combine patient vital signs monitoring with a web application that streamlines patient care management. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access our web-based applications thereby utilizing previous investments in systems and technology. The company's healthcare customers and users include leading homecare companies, health systems, and physician groups. These organizations utilize the company's products and services to coordinate care for patients outside of acute care.
For more information, visit www.authentidate.com
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words "believe," "anticipate," "think," "intend," "plan," "will be," "expect," and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company's ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.
Authentidate, Inscrybe and InscrybeMD are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.
CONTACT: Media Contacts: Authentidate Holding Corp. James Carbonara, Hayden IR,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
(646) 755-7412 Brett Maas, Hayden IR,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
(646) 536-7331
Copyright (C) 2015 GlobeNewswire, Inc. All rights reserved.
|
|
Extravascular stent management for migration of left renal vein endovascular ... - BMC Blogs Network |
Endovascular stenting has been used for seventeen years for the treatment of NCS due to its minimally invasive nature. A survey of the published English literature revealed 124 cases treated in this manner including our largest stenting experiences to date [2]–[9]. Although, the current literature suggests that stenting is a safe and effective procedure, stent migration notes in 7.3 % of all cases [2]–[5]. The reason of endovascular stent migration may be the effect of cardiac motion, early activity, mismatch between renal vein diameter or stent diameter, or inaccurate positioning of the stent within the lesion.
The clinical implications of migration are significant and can lead to thrombosis, vessel trauma, embolization, and its most disastrous consequence (rupture). It requires prompt and effective diagnosis and management to prevent potentially implications.
Sequence of image for diagnosis or follow-up has more or less been rationalized to duplex ultrasound, computerized tomography or magnetic resonance angiography, and finally left renal venography [2]. Duplex ultrasound is the easiest and the least expensive method. Zhelan Zheng et al. [10] pointed out standards for ultrasonic diagnosis of the disease as follows: (1)the low velocity of stenosis of the LRV at supine position accelerates remarkably, and the acceleration is more obvious after standing for 15 min,which is more than 100 cm/s; (2) the inner diameter ratio between renal hilum and stenosis of the LRV at supine position is more than 3, while it is more than 5 after standing for 15 min. When two index are coincident with the standards, NCS may be primary diagnosed. The CTA (including non-invasive 3-D) may be a useful tool in the diagnosis of the NCS and follow-up testing. CTA provided fine outlines that gave a precise depiction of both endovascular stent migration on the left of the SMA and a compression of the LRV between the aorta and the SMA. Furthermore, the stent migrating distance can be measured, and many distorting collateral veins were seen arising from the LRV in the CTA. The CTA imaging was closely correlated to therapeutic interventions and stent migration.
The typical treatment is percutaneous removal of the migrated stent. However, under certain circumstances, such as stent migration to the heart, special stent, or endothelialization of stent, percutaneous removal may be difficult or even impossible, thus surgery may be required. Hartung et al. described a LRV stent that migrated into the retro hepatic inferior vena cava; an attempt to retrieve it with a Goose Neck failed when the stent took a transversal orientation after 5 cm, and further attempts also failed [4]. A patient with a nitinol stent is difficult to manage percutaneously because of its inherent characteristics and probable endothelialization of the stent in 1 year, which makes the procedure more challenging [11]. In our previous case, one stent migrated into the right atrium and the patient required surgery after unsuccessful percutaneous removal [3]. In such cases, surgical removal is a safer and more feasible option. However, surgical removal is associated with high morbidity: Long period of renal congestion and additional anastomoses. Compared with surgical removal, extravascular stenting is a minimally invasive treatment modality.
Compared with vascular displacement, extravascular stenting for NCS is a minimally invasive treatment modality. Especially for children and adolescents, intravascular stenting should be cautiously recommended because the lumen of the LRV may become wider and the stents cannot match any longer during physical development. One may postulate that externally suturing stent could be a way to keep it in place; therefore, Barnes firstly reported extravascular stenting and externally suturing the stent performed by open surgery in 1988 [12]. Currently, sporadic cases of extravascular stenting for the NCS have been reported with excellent outcome at short-term follow up [13]–[17]. The stent has good conformability to adapt to the vessel wall and adhere to the vessel wall tightly [6]. In our opinion, the extravascular approach to treat endovascular stent migration is favored to avoid the potential complications.
Consideration must also be given to the original stent placement. If removal is not possible or failed, the original stent should be fixed to prevent repeated movements of the stent. Both the new and old stents should be sewn to the vessel wall to ensure that the extravascular and endovascular stents did not migrate, as shown in our case.
|
BMC Urology | Full text | Extravascular stent management for migration of left ... - BMC Blogs Network |
Endovascular stenting has been used for seventeen years for the treatment of NCS due to its minimally invasive nature. A survey of the published English literature revealed 124 cases treated in this manner including our largest stenting experiences to date [2]–[9]. Although, the current literature suggests that stenting is a safe and effective procedure, stent migration notes in 7.3 % of all cases [2]–[5]. The reason of endovascular stent migration may be the effect of cardiac motion, early activity, mismatch between renal vein diameter or stent diameter, or inaccurate positioning of the stent within the lesion.
The clinical implications of migration are significant and can lead to thrombosis, vessel trauma, embolization, and its most disastrous consequence (rupture). It requires prompt and effective diagnosis and management to prevent potentially implications.
Sequence of image for diagnosis or follow-up has more or less been rationalized to duplex ultrasound, computerized tomography or magnetic resonance angiography, and finally left renal venography [2]. Duplex ultrasound is the easiest and the least expensive method. Zhelan Zheng et al. [10] pointed out standards for ultrasonic diagnosis of the disease as follows: (1)the low velocity of stenosis of the LRV at supine position accelerates remarkably, and the acceleration is more obvious after standing for 15 min,which is more than 100 cm/s; (2) the inner diameter ratio between renal hilum and stenosis of the LRV at supine position is more than 3, while it is more than 5 after standing for 15 min. When two index are coincident with the standards, NCS may be primary diagnosed. The CTA (including non-invasive 3-D) may be a useful tool in the diagnosis of the NCS and follow-up testing. CTA provided fine outlines that gave a precise depiction of both endovascular stent migration on the left of the SMA and a compression of the LRV between the aorta and the SMA. Furthermore, the stent migrating distance can be measured, and many distorting collateral veins were seen arising from the LRV in the CTA. The CTA imaging was closely correlated to therapeutic interventions and stent migration.
The typical treatment is percutaneous removal of the migrated stent. However, under certain circumstances, such as stent migration to the heart, special stent, or endothelialization of stent, percutaneous removal may be difficult or even impossible, thus surgery may be required. Hartung et al. described a LRV stent that migrated into the retro hepatic inferior vena cava; an attempt to retrieve it with a Goose Neck failed when the stent took a transversal orientation after 5 cm, and further attempts also failed [4]. A patient with a nitinol stent is difficult to manage percutaneously because of its inherent characteristics and probable endothelialization of the stent in 1 year, which makes the procedure more challenging [11]. In our previous case, one stent migrated into the right atrium and the patient required surgery after unsuccessful percutaneous removal [3]. In such cases, surgical removal is a safer and more feasible option. However, surgical removal is associated with high morbidity: Long period of renal congestion and additional anastomoses. Compared with surgical removal, extravascular stenting is a minimally invasive treatment modality.
Compared with vascular displacement, extravascular stenting for NCS is a minimally invasive treatment modality. Especially for children and adolescents, intravascular stenting should be cautiously recommended because the lumen of the LRV may become wider and the stents cannot match any longer during physical development. One may postulate that externally suturing stent could be a way to keep it in place; therefore, Barnes firstly reported extravascular stenting and externally suturing the stent performed by open surgery in 1988 [12]. Currently, sporadic cases of extravascular stenting for the NCS have been reported with excellent outcome at short-term follow up [13]–[17]. The stent has good conformability to adapt to the vessel wall and adhere to the vessel wall tightly [6]. In our opinion, the extravascular approach to treat endovascular stent migration is favored to avoid the potential complications.
Consideration must also be given to the original stent placement. If removal is not possible or failed, the original stent should be fixed to prevent repeated movements of the stent. Both the new and old stents should be sewn to the vessel wall to ensure that the extravascular and endovascular stents did not migrate, as shown in our case.
|
Mississippi CON Report - July 2015 - Lexology - Lexology (registration) |
- June 2015 – Mississippi Certificate of Need Meeting
During the June 25, 2015, Certificate of Need meeting, Dr. Mary Currier, State Health Officer, concurred with the health and planning staff analysis and approved the following applications for Certificate of Need:
CON Review #HG-MOB-0215-003 – Madison HMA LLC d/b/a Merit Health Madison – Construction of a Medical Office Building (MOB) – Location: Canton, Madison County, Mississippi – Capital Expenditure: $9,000,000 – Staff Recommendation: Approval
CON Review #C-NIS-0215-004 – Cardiovascular Solutions of Mississippi LLC d/b/a Cardiovascular Solutions of Mississippi – Provision of Digital Subtraction Angiography (DSA) Services – Location: Grenada, Grenada County, Mississippi – Capital Expenditure: $250,000 – Staff Recommendation: Approval
The next Certificate of Need meeting is scheduled for July 30, 2015, at 11:00 a.m.
- Certificate of Need Program Report – Filings/Reports in June 2015
- Letters of Intent to Change Ownership
- Holmes County LTC Center – Change of Ownership – Received June 3, 2015
- Determinations of Reviewability
- RCG of Oxford d/b/a Oxford Home Therapy – Establishment of a Home Dialysis Program - Received June 1, 2015
- Mississippi Medical Options LLC – Mississippi Medical Options Geriatric Psychiatric Unit - Received June 1, 2015
- Anderson Regional Medical Center – Acquisition of a Replacement Cardiac Catheterization System and the Installation of the New Equipment at Anderson Regional Medical Center in Meridian – Received June 1, 2015
- University of Mississippi Medical Center – Additional MRI for Children’s of Mississippi –Received June 15, 2015
- Biloxi HMA LLC d/b/a Merit Health Biloxi (f.k.a Biloxi Regional Medical Center) – Merger of Compass Imaging LLC – Received June 19, 2015
- University of Mississippi Medical Center – Emergency Department Chest Pain Evaluation Unit – Received June 19, 2015
- Letters of Intent to Apply for CON
- Bio-Medical Applications of Mississippi Inc. d/b/a Fresenius Medical Care – West Hinds – CON Amendment – Bio-Medical Applications of Mississippi Inc. d/b/a Fresenius Medical Care – West Hinds County – Establishment of Satellite ESRD Facility – Received June 1, 2015
- Cedar Lake Open MRI LLC d/b/a Cedar Lake Open MRI – Offering of MRI Services and Acquisition of MRI Equipment – Received June 24, 2015
- Applications Received/Withdrawn
- St. Dominic Jackson Memorial Hospital – Renovation and Expansion of Emergency Department – Received May 29, 2015
- Hattiesburg Clinic Professional Association – Offering of Diagnostic Imaging Services of an Invasive Nature, including Digital Subtraction Angiography – Received June 1, 2015
- Bio-Medical Applications of Mississippi Inc. d/b/a Fresenius Medical Care Dialysis Services of Rankin County – Brandon – Relocation of ESRD Facility within One Mile and Expansion of ESRD Stations – Received June 1, 2015
- Bio-Medical Applications of Mississippi Inc. d/b/a Fresenius Medical Care – West Hinds – CON Amendment – Bio-Medical Applications of Mississippi Inc. d/b/a Fresenius Medical Care – West Hinds County – Establishment of Satellite ESRD Facility – Received June 1, 2015
- Singing River Health System d/b/a Singing River Hospital – Exterior Hardening Window Replacement – Received June 1, 2015
- NeuroTASS LLC – Establishment of Comprehensive Residential Rehabilitation Facility – Received June 1, 2015
- ?Applications Received for Extension/Renewal of an Expired CON
None
- Additional Material Received in Response to Negative Staff Analysis
None
- CON Applications Deemed Complete
None
- Six-Month Extension Requests Granted
- SME on HG-RE-0808-030; R-0780 – North Mississippi Medical Center – Replacement and Addition of Electronic Information and Surgery Information Systems – Capital Expenditure: $28,000 – Expiration Date: September 15, 2015
- SME on HG-R-1209-035; R-0807 – Mississippi Baptist Medical Center – Nursing Units Renovation Project – Capital Expenditure: $58,650,000 – Expiration Date: September 25, 2015
- SME on HG-CRF-1203-035; R-0636 – Alliance Healthcare Inc. System d/b/a Alliance Health Care System – Construction of Replacement Hospital – Capital Expenditure: $30,807,769 – Expiration Date: September 25, 2015
- SME on HG-RC-1109-030; R-0804 – North Mississippi Medical Center – West Bed-Tower Expansion and Renovation – Capital Expenditure: $55,103,273 – Expiration Date: September 25, 2015
- SME on HG-RC-0613-008; R-0868 – Baptist Memorial Hospital North Mississippi, Inc. d/b/a Baptist Memorial North Mississippi – Hospital Infusion Services Addition – Capital Expenditure: $4,153,323 – Expiration Date: September 28, 2015
- SME on ESRD-NIS-0612-013; R-0859 – RCG Mississippi Inc. d/b/a Lowndes County Dialysis, Columbus – Establishment of Satellite ESRD Facility – Capital Expenditure: $1,405,966 – Expiration Date: September 28, 2015
- SME on HG-C-0613-010; R-0870 – Mississippi Methodist Hospital and Rehabilitation Center Inc. d/b/a Methodist Outpatient Rehabilitation – Construction of Consolidated Outpatient Therapy Facility – Capital Expenditure: $5,872,945 – Expiration Date: September 28, 2015
- SME on HG-RC-0611-013; R-0847 – Memorial Hospital at Gulfport, Gulfport Neonatal Intensive Care Unit Expansion – Capital Expenditure: $6,663,350 – Expiration Date: September 29, 2015
- SME on HG-CB-1211-027; R-0848 – Singing River Hospital, Pascagoula – Addition of Level II Comprehensive Medical Rehabilitation Beds – Capital Expenditure: $690,000 – Expiration Date: September 29, 2015
- SME on NH-CRF-0908-039; R-0786 – Community Place Jackson – Construction/ Replacement/Relocation of Community Nursing Home – Capital Expenditure: $9,870,000 - Expiration Date: October 30, 2015
- Hearings Requested/Scheduled During the Course of Review
None
- Request for Hearing on Denial of Six-Month Extension
CON Review #ESRD-NIS-0905-041; CON #R-0710 – Healthcare Engineers LLC – Establishment of a Six-Station ESRD Facility in Tallahatchie County – Capital Expenditure: $254,085 – Requestor: Alliance Health Partners LLC d/b/a Tri-Lakes Medical Center – To Be Scheduled
|
Blacks at Higher Risk of Sudden Cardiac Arrest - Renal and Urology News - Renal and Urology News |
July 23, 2015
Higher rates of sudden cardiac arrest are seen in blacks versus whites and often at younger ages.
(HealthDay News) -- Blacks are more likely than whites to experience sudden cardiac arrest and it often occurs at an earlier age in blacks than in whites, according to research published online in Circulation.
Sumeet Chugh, M.D., associate director of the Cedars-Sinai Heart Institute in Los Angeles, and colleagues collected data on 1,262 whites and 126 blacks. They all had experienced sudden cardiac arrest between 2002 and 2012. While 33% of the whites in the study had diabetes, 52% of the blacks did. Hypertension was an issue for 77% of the blacks, compared to 65% of the whites. Chronic renal insufficiency was nearly twice as likely in blacks, with 34% of them having the condition, the researchers found.
Blacks in the United States tend to have sudden cardiac arrest an average of 6 years earlier than whites, Chugh told HealthDay. In his study, he found other major differences as well. "Blacks, in addition to being younger, tended to have more diabetes, more high blood pressure, and more kidney problems, or chronic renal disease," he said.
Chugh added that he isn't certain what's driving the differences in sudden cardiac arrest between blacks and whites. It's possible it might be genetics, cultural differences in lifestyle or other factors, he suggested. Inadequate health coverage may be another factor.
Source
- Reinier, K; Nichols, GA; Huertas-Vazquez, A; et al. Circulation, published online before print July 20, 2015; doi: 10.1161/CIRCULATIONAHA.115.015673.
|
|
|